Dew, how do you see this news affecting the approvability of DX-88. Looks like a vote of no confidence. Alternatively, it could be a strategic decision for GENZ (too many trials, for too long, for not too much money).
Also, this news makes the recent runup even more confusing.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.